<p>/PRNewswire/ -- Collaborative Drug Discovery (CDD)，製藥和生物技術行業領先的數據管理解決方案提供商，今天宣佈與禮來公司（Eli Lilly and Company）達成協議，將禮來 TuneLab 這一協作式 AI/ML 藥物發現平台整合到 CDD Vault 中。</p>
<p><img src="https://imageproxy.pbkrs.com/https://mma.prnewswire.com/media/2983026/Collaborative_Drug_Discovery_Logo.jpg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="400" height="197" original-src="https://imageproxy.pbkrs.com/https://mma.prnewswire.com/media/2983026/Collaborative_Drug_Discovery_Logo.jpg"/></p>
<p>禮來 TuneLab 是由禮來創建的，旨在通過使參與公司能夠訪問基於禮來數十年的專有研究數據訓練的模型，從而加速生物技術創新。通過這項協議，使用 CDD Vault 的生物技術公司將能夠在其自然科學工作流程中利用選定的禮來預測模型。</p>
<p>&#34;通過將 TuneLab 直接整合到 CDD Vault 中，我們正在推進 CDD 的核心願景，以促進藥物發現團隊和組織之間的協作。我們相信，解決藥物發現中最複雜的挑戰將依賴於創新的協作模型，這些模型提供廣泛的研究數據訪問，並使化學家和生物學家能夠做出基於數據的明智決策，&#34; CDD 首席執行官兼總裁 Barry A. Bunin 説。&#34;TuneLab 的 ADMET 模型將適應我們可信的安全 CDD Vault 軟件環境，融入實驗和計算科學家的自然工作流程，以及我們不斷壯大的 CDD Vault 生物製藥公司生態系統。&#34;</p>
<p>這項協議為計劃在 CDD Vault 中整合禮來 TuneLab 的核心模塊和 AI 模塊鋪平了道路，供選擇參與該項目的生物技術公司使用。它建立在 CDD 自 2004 年成立以來的願景之上：展示基於網絡的協作的效率經濟。</p>
<p>&#34;TuneLab 的模型與我們的創新相輔相成，例如零點擊模型、生成性生物等效物，以及與 SureChEMBL 的超快速深度學習相似性，以便於新穎性和 Enamine 庫的便利 SAR-by-catalog，&#34; CDD 研究信息學高級科學家 Dr. Peter Gedeck 分享道。</p>
<p><strong>關於 Collaborative Drug Discovery, Inc.</strong> CDD 的旗艦產品 CDD Vault® 是一個用於安全管理和共享生物和化學研究數據的高級託管數據庫解決方案。CDD Vault 提供化學和生物註冊管理、結構 - 活性關係（SAR）和實驗組織的工具。該平台的可用模塊包括註冊、活動與可視化、測定、電子實驗室筆記本、庫存、曲線、人工智能和自動化。<strong>www.collaborativedrug.com</strong></p>
<p><strong>媒體聯繫人：</strong></p>
<p>Janice Darlington</p>
<p>619-393-2220</p>
<p>jdarlington@collaborativedrug.com</p>
<p><img src="https://imageproxy.pbkrs.com/https://mma.prnewswire.com/media/2983027/Collaborative_Drug_Discovery_Partners_with_Lilly_TuneLab.jpg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="400" height="145" original-src="https://imageproxy.pbkrs.com/https://mma.prnewswire.com/media/2983027/Collaborative_Drug_Discovery_Partners_with_Lilly_TuneLab.jpg"/></p>
<p><img src="https://imageproxy.pbkrs.com/https://edge.prnewswire.com/c/img/favicon.png/query-c2Q9MjAyNi0wNS0yMCZzbj1TRjYyODMy?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="16" height="16" original-src="https://imageproxy.pbkrs.com/https://edge.prnewswire.com/c/img/favicon.png/query-c2Q9MjAyNi0wNS0yMCZzbj1TRjYyODMy"/></p>
<p>查看原始內容以下載多媒體：https://www.prnewswire.com/news-releases/collaborative-drug-discovery-partners-with-lilly-tunelab-to-make-lilly-aiml-models-available-in-cdd-vault-302777087.html</p>
<p>來源：Collaborative Drug Discovery, Inc.</p>

禮來

2 倍做多 LLY ETF - Defiance

標普生物技術 3 倍做多 - Direxion

標普生物技術 3 倍做空 - Direxion

2 倍做多 LLY ETF - Direxion

1 倍做空 LLY ETF - Direxion

LLYZ

<p>Collaborative Drug Discovery (CDD) 與禮來（Eli Lilly）合作，將禮來 TuneLab 這一人工智能/機器學習藥物發現平台整合到 CDD Vault 中。這一合作使得使用 CDD Vault 的生物技術公司能夠訪問禮來的預測模型，從而增強藥物發現中的數據驅動決策。CDD 的首席執行官 Barry A. Bunin 強調了在應對該領域複雜挑戰時合作的重要性。此次整合旨在簡化科學家的工作流程，並支持 CDD 高效的基於網絡的協作願景</p>

<p>, /PRNewswire/ -- Collaborative Drug Discovery (CDD), the leading provider of data management solutions for the pharmaceutical and biotechnology industries, today announced an agreement with Eli Lilly and Company (Lilly) to integrate Lilly TuneLab, a collaborative AI/ML drug discovery platform, into CDD Vault.</p>
<div class="lb-trans"><p>/PRNewswire/ -- Collaborative Drug Discovery (CDD)，製藥和生物技術行業領先的數據管理解決方案提供商，今天宣佈與禮來公司（Eli Lilly and Company）達成協議，將禮來 TuneLab 這一協作式 AI/ML 藥物發現平台整合到 CDD Vault 中。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://mma.prnewswire.com/media/2983026/Collaborative_Drug_Discovery_Logo.jpg" alt="" original-src="https://mma.prnewswire.com/media/2983026/Collaborative_Drug_Discovery_Logo.jpg"/></p>
<p>Lilly TuneLab was created by Lilly to accelerate biotech innovation by enabling participating companies to access models trained on decades of Lilly's proprietary research data. Through this agreement, biotech companies that use CDD Vault will be able to utilize select Lilly predictive models within their natural scientific workflows.</p>
<div class="lb-trans"><p>禮來 TuneLab 是由禮來創建的，旨在通過使參與公司能夠訪問基於禮來數十年的專有研究數據訓練的模型，從而加速生物技術創新。通過這項協議，使用 CDD Vault 的生物技術公司將能夠在其自然科學工作流程中利用選定的禮來預測模型。</p>
</div><p>&#34;By integrating TuneLab directly into CDD Vault, we are advancing CDD's core vision to enable collaboration across drug discovery teams and organizations. We believe that solving the most complex challenges in drug discovery will depend on innovative collaboration models that provide broad access to research data and empower chemists and biologists to make informed, data-driven decisions,&#34; said Barry A. Bunin, CDD Chief Executive Officer and President. &#34;TuneLab's ADMET models will fit in our trusted secure CDD Vault software environment in natural workflows for experimental and computational scientists and with our growing CDD Vault ecosystem of biopharmaceutical companies.&#34;</p>
<div class="lb-trans"><p>&#34;通過將 TuneLab 直接整合到 CDD Vault 中，我們正在推進 CDD 的核心願景，以促進藥物發現團隊和組織之間的協作。我們相信，解決藥物發現中最複雜的挑戰將依賴於創新的協作模型，這些模型提供廣泛的研究數據訪問，並使化學家和生物學家能夠做出基於數據的明智決策，&#34; CDD 首席執行官兼總裁 Barry A. Bunin 説。&#34;TuneLab 的 ADMET 模型將適應我們可信的安全 CDD Vault 軟件環境，融入實驗和計算科學家的自然工作流程，以及我們不斷壯大的 CDD Vault 生物製藥公司生態系統。&#34;</p>
</div><p>This agreement paves the way for the planned integration of Lilly TuneLab in both the core and AI modules within CDD Vault for biotech companies that opt in to the program. It builds on CDD's founding vision from 2004: to demonstrate the economics of efficiency of web-based collaboration.</p>
<div class="lb-trans"><p>這項協議為計劃在 CDD Vault 中整合禮來 TuneLab 的核心模塊和 AI 模塊鋪平了道路，供選擇參與該項目的生物技術公司使用。它建立在 CDD 自 2004 年成立以來的願景之上：展示基於網絡的協作的效率經濟。</p>
</div><p>&#34;TuneLab's models are synergistic with our innovations such as Zero Click Models, Generative Bioisosteres, as well as Ultrafast Deep Learning similarity to SureChEMBL for novelty and Enamine libraries for convenient SAR-by-catalog,&#34; shared CDD Research Informatics Senior Scientist Dr. Peter Gedeck.</p>
<div class="lb-trans"><p>&#34;TuneLab 的模型與我們的創新相輔相成，例如零點擊模型、生成性生物等效物，以及與 SureChEMBL 的超快速深度學習相似性，以便於新穎性和 Enamine 庫的便利 SAR-by-catalog，&#34; CDD 研究信息學高級科學家 Dr. Peter Gedeck 分享道。</p>
</div><p><strong>About Collaborative Drug Discovery, Inc.</strong> CDD's flagship product, CDD Vault®, is a premier hosted database solution for the secure management and sharing of biological and chemical research data. CDD Vault provides tools for chemical and biological registration management, structure-activity relationships (SAR), and experiment organization. The platform's available modules include Registration, Activity &amp; Visualization, Assays, ELN, Inventory, Curves, AI, and Automation. <strong>www.collaborativedrug.com</strong></p>
<div class="lb-trans"><p><strong>關於 Collaborative Drug Discovery, Inc.</strong> CDD 的旗艦產品 CDD Vault® 是一個用於安全管理和共享生物和化學研究數據的高級託管數據庫解決方案。CDD Vault 提供化學和生物註冊管理、結構 - 活性關係（SAR）和實驗組織的工具。該平台的可用模塊包括註冊、活動與可視化、測定、電子實驗室筆記本、庫存、曲線、人工智能和自動化。<strong>www.collaborativedrug.com</strong></p>
</div><p><strong>Media Contact:</strong></p>
<div class="lb-trans"><p><strong>媒體聯繫人：</strong></p>
</div><p>Janice Darlington</p>
<div class="lb-trans"><p>Janice Darlington</p>
</div><p>619-393-2220</p>
<div class="lb-trans"><p>619-393-2220</p>
</div><p>jdarlington@collaborativedrug.com</p>
<div class="lb-trans"><p>jdarlington@collaborativedrug.com</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://mma.prnewswire.com/media/2983027/Collaborative_Drug_Discovery_Partners_with_Lilly_TuneLab.jpg" alt="" original-src="https://mma.prnewswire.com/media/2983027/Collaborative_Drug_Discovery_Partners_with_Lilly_TuneLab.jpg"/></p>
<p><img src="https://imageproxy.pbkrs.com/https://edge.prnewswire.com/c/img/favicon.png/query-c2Q9MjAyNi0wNS0yMCZzbj1TRjYyODMy" alt="" original-src="https://edge.prnewswire.com/c/img/favicon.png?sn=SF62832&amp;sd=2026-05-20"/></p>
<p>View original content to download multimedia:https://www.prnewswire.com/news-releases/collaborative-drug-discovery-partners-with-lilly-tunelab-to-make-lilly-aiml-models-available-in-cdd-vault-302777087.html</p>
<div class="lb-trans"><p>查看原始內容以下載多媒體：https://www.prnewswire.com/news-releases/collaborative-drug-discovery-partners-with-lilly-tunelab-to-make-lilly-aiml-models-available-in-cdd-vault-302777087.html</p>
</div><p>SOURCE Collaborative Drug Discovery, Inc.</p>
<div class="lb-trans"><p>來源：Collaborative Drug Discovery, Inc.</p>
</div>

Collaborative Drug Discovery 與禮來 TuneLab 合作，將禮來的 AI/ML 模型整合到 CDD Vault 中